AACR Annual Meeting 2023: The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
Results from the phase III clinical trial BELLE-3, presented at the San Antonio Breast Cancer Symposium on Dec. 8,...
January is Cervical Cancer Awareness Month. Given that January was named after the Roman god Janus, whose two faces...
Stepping onto the exhibit floor at an Annual Meeting poster session is a memorable experience. Row upon row of...
This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....
Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
Although childhood cancer is rare, it represents the leading cause of death by disease in children in developed countries....
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
As we finally welcome spring, enjoy this hand-picked selection of articles brought to you by the editors of the...
Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause...
The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at...
Raymond DuBois, MD, PhD, past-president of the AACR (2008-2009), fellow of the AACR Academy, and chairman and president of...
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
Back for the month of October are the editors’ picks from the eight esteemed scientific journals published by the...
Liquid biopsies, noninvasive tests performed on biofluids to detect genetic alterations in tumors, are a recent revolution in the...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we...
Two graduates of the AACR Scientist↔Survivor Program, a special educational experience that gives patient advocates the opportunity to attend...
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
This post originally appeared on the Cancer Today website. “This is a historic time in cancer research,” said Elizabeth...
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the...
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today The artificial intelligence (AI) revolution has important implications for...
Across the surfaces of your mouth, throat, and nasal sinuses, layers of flat cells called squamous cells protect the...